GGrantIndex
← Search

A PHASE II STUDY OF THE PREDICTIVE VALUE OF PHARMACOKINETIC-ADJUSTED PHENOTYPIC

$17,213M01FY2005RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →